325 related articles for article (PubMed ID: 25485719)
1. Ca²⁺ signal-induced cardiomyocyte hypertrophy through activation of myocardin.
Li M; Wang N; Gong HQ; Li WZ; Liao XH; Yang XL; He HP; Cao DS; Zhang TC
Gene; 2015 Feb; 557(1):43-51. PubMed ID: 25485719
[TBL] [Abstract][Full Text] [Related]
2. The synergistic effects of cytomegalovirus IE2 and myocardin on cardiomyocyte hypertrophy.
Zhou J; Liao XH; Wu C; Li J; Xiao R; Cheng C; Wang N; Cao D; Zhang TC
FEBS Lett; 2011 Apr; 585(7):1082-8. PubMed ID: 21385583
[TBL] [Abstract][Full Text] [Related]
3. Myocardin induces cardiomyocyte hypertrophy.
Xing W; Zhang TC; Cao D; Wang Z; Antos CL; Li S; Wang Y; Olson EN; Wang DZ
Circ Res; 2006 Apr; 98(8):1089-97. PubMed ID: 16556869
[TBL] [Abstract][Full Text] [Related]
4. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K
Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476
[TBL] [Abstract][Full Text] [Related]
5. NFATc4 and myocardin synergistically up-regulate the expression of LTCC α1C in ET-1-induced cardiomyocyte hypertrophy.
Li M; He HP; Gong HQ; Zhang J; Ma WJ; Zhou H; Cao DS; Wang N; Zhang TC
Life Sci; 2016 Jun; 155():11-20. PubMed ID: 27155398
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase Cα inhibits myocardin-induced cardiomyocyte hypertrophy through the promotion of myocardin phosphorylation.
Li W; Wang N; Li M; Gong H; Liao X; Yang X; Zhang T
Acta Biochim Biophys Sin (Shanghai); 2015 Sep; 47(9):687-95. PubMed ID: 26206583
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase 3beta inhibits myocardin-dependent transcription and hypertrophy induction through site-specific phosphorylation.
Badorff C; Seeger FH; Zeiher AM; Dimmeler S
Circ Res; 2005 Sep; 97(7):645-54. PubMed ID: 16141410
[TBL] [Abstract][Full Text] [Related]
8. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
9. NF-κB (p65) negatively regulates myocardin-induced cardiomyocyte hypertrophy through multiple mechanisms.
Liao XH; Wang N; Zhao DW; Zheng DL; Zheng L; Xing WJ; Zhou H; Cao DS; Zhang TC
Cell Signal; 2014 Dec; 26(12):2738-48. PubMed ID: 25152367
[TBL] [Abstract][Full Text] [Related]
10. Role of heterotrimeric G protein and calcium in cardiomyocyte hypertrophy induced by IGF-1.
Carrasco L; Cea P; Rocco P; Peña-Oyarzún D; Rivera-Mejias P; Sotomayor-Flores C; Quiroga C; Criollo A; Ibarra C; Chiong M; Lavandero S
J Cell Biochem; 2014 Apr; 115(4):712-20. PubMed ID: 24243530
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes.
Chiu CZ; Wang BW; Chung TH; Shyu KG
Clin Sci (Lond); 2010 Jun; 119(7):273-82. PubMed ID: 20446923
[TBL] [Abstract][Full Text] [Related]
12. Effect of distinct sources of Ca(2+) on cardiac hypertrophy in cardiomyocytes.
Xu H; Zhang Y; Sun J; Wei J; Sun L; Zhang J
Exp Biol Med (Maywood); 2012 Mar; 237(3):271-8. PubMed ID: 22345300
[TBL] [Abstract][Full Text] [Related]
13. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin.
Jiang DS; Luo YX; Zhang R; Zhang XD; Chen HZ; Zhang Y; Chen K; Zhang SM; Fan GC; Liu PP; Liu DP; Li H
Hypertension; 2014 Jan; 63(1):119-27. PubMed ID: 24144649
[TBL] [Abstract][Full Text] [Related]
15. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy.
Nelson TJ; Balza R; Xiao Q; Misra RP
J Mol Cell Cardiol; 2005 Sep; 39(3):479-89. PubMed ID: 15950986
[TBL] [Abstract][Full Text] [Related]
16. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
Dai H; Jia G; Liu X; Liu Z; Wang H
Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
[TBL] [Abstract][Full Text] [Related]
17. Use of atorvastatin to inhibit hypoxia-induced myocardin expression.
Chiu CZ; Wang BW; Shyu KG
Eur J Clin Invest; 2012 May; 42(5):564-71. PubMed ID: 22129233
[TBL] [Abstract][Full Text] [Related]
18. CaMKII activates ASK1 and NF-kappaB to induce cardiomyocyte hypertrophy.
Kashiwase K; Higuchi Y; Hirotani S; Yamaguchi O; Hikoso S; Takeda T; Watanabe T; Taniike M; Nakai A; Tsujimoto I; Matsumura Y; Ueno H; Nishida K; Hori M; Otsu K
Biochem Biophys Res Commun; 2005 Feb; 327(1):136-42. PubMed ID: 15629441
[TBL] [Abstract][Full Text] [Related]
19. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of myocardial hypertrophy regulated by the interaction between mhrt and myocardin.
Luo Y; Xu Y; Liang C; Xing W; Zhang T
Cell Signal; 2018 Mar; 43():11-20. PubMed ID: 29199045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
